Welcome to the UCL Cancer Institute
The UCL Cancer Institute is the hub for cancer research at University College London, one of the World's leading universities. The Institute draws together over 300 talented scientists who are working together to translate research discoveries into developing better, more effective treatments to improve outcomes for cancer patients. If you are thinking about taught postgraduate study, applications to our flagship MSc Cancer programme are now open for the academic year 2017/18.
Human Papillomavirus (HPV) drives a greater number of head and neck cancers than previously thought, finds new research from UCL and the University of Southampton. The findings, published in the Journal of Clinical Oncology, offer valuable insight into the role of HPV in tumour development and explore the possibility of a viable treatment option for specific cancer patients.
Published: Oct 6, 2016 5:15:24 PM
A new spin-out company, Achilles Therapeutics, has been launched to develop immunotherapies for cancer, based on the work of scientists from UCL and its associated hospitals. The new company will bring together world-class research from UCL and the Francis Crick Institute, funded by Cancer Research UK and the National Institute for Health Research.
Published: Oct 6, 2016 8:36:56 AM
UCL’s three biomedical research centres (BRCs) have won more than £167 million in funding from the National Institute for Health Research (NIHR) to further world-leading biomedical research conducted with partner hospitals. UCL has received more funding than any other UK university, followed by King's College London and Oxford University, which received £133m and £127m respectively.
Published: Sep 27, 2016 10:14:46 AM
For the first time, a team including UCL researchers has identified in human cancers two characteristic patterns of DNA damage caused by ionising radiation. These fingerprint patterns may now enable doctors to identify which tumours have been caused by radiation, and investigate if they should be treated differently.
Published: Sep 12, 2016 5:09:44 PM
Places are still available for this event. View programme and register for your place.
Starts: Nov 7, 2016 12:00:00 PM
Organised by the UCL Personalised Medicine Domain, in partnership with UCL Partners the symposium will bring together around 250 group leaders and post-doctoral researchers from across UCL and Queen Mary University of London.
Starts: Nov 8, 2016 9:00:00 AM
Support our work
Find out how you can help us to continue research that will lead to breakthroughs in cancer therapies and benefit the lives of cancer patients.